Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Overview of medical device regulation in Japan as it relates to orthopedic devices.

Yamaguchi U, Chuman H.

J Orthop Sci. 2013 Sep;18(5):866-8. doi: 10.1007/s00776-013-0418-x. Epub 2013 Jun 11. No abstract available.

PMID:
23754149
2.

Minimally invasive solid long segmental fixation combined with direct decompression in patients with spinal metastatic disease.

Lin F, Yamaguchi U, Matsunobu T, Kobayashi E, Nakatani F, Kawai A, Chuman H.

Int J Surg. 2013;11(2):173-7. doi: 10.1016/j.ijsu.2012.12.016. Epub 2012 Dec 27.

3.

Diagnostic and prognostic significance of the alternatively spliced ACTN4 variant in high-grade neuroendocrine pulmonary tumours.

Miyanaga A, Honda K, Tsuta K, Masuda M, Yamaguchi U, Fujii G, Miyamoto A, Shinagawa S, Miura N, Tsuda H, Sakuma T, Asamura H, Gemma A, Yamada T.

Ann Oncol. 2013 Jan;24(1):84-90. doi: 10.1093/annonc/mds215. Epub 2012 Aug 10.

PMID:
22887464
4.

Massive ossification around the prosthesis after limb salvage treatment for osteosarcoma.

Lin F, Yamaguchi U, Beppu Y, Kawai A, Chuman H.

J Orthop Sci. 2013 Jul;18(4):667-70. doi: 10.1007/s00776-012-0199-7. Epub 2012 Mar 8. No abstract available.

PMID:
22399106
5.

Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma.

Kobayashi E, Masuda M, Nakayama R, Ichikawa H, Satow R, Shitashige M, Honda K, Yamaguchi U, Shoji A, Tochigi N, Morioka H, Toyama Y, Hirohashi S, Kawai A, Yamada T.

Mol Cancer Ther. 2010 Mar;9(3):535-44. doi: 10.1158/1535-7163.MCT-09-0774. Epub 2010 Feb 16.

6.

Functional genome screen for therapeutic targets of osteosarcoma.

Yamaguchi U, Honda K, Satow R, Kobayashi E, Nakayama R, Ichikawa H, Shoji A, Shitashige M, Masuda M, Kawai A, Chuman H, Iwamoto Y, Hirohashi S, Yamada T.

Cancer Sci. 2009 Dec;100(12):2268-74. doi: 10.1111/j.1349-7006.2009.01310.x. Epub 2009 Aug 10.

7.

Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas.

Kikuchi S, Honda K, Tsuda H, Hiraoka N, Imoto I, Kosuge T, Umaki T, Onozato K, Shitashige M, Yamaguchi U, Ono M, Tsuchida A, Aoki T, Inazawa J, Hirohashi S, Yamada T.

Clin Cancer Res. 2008 Sep 1;14(17):5348-56. doi: 10.1158/1078-0432.CCR-08-0075.

8.

Distinct gene expression-defined classes of gastrointestinal stromal tumor.

Yamaguchi U, Nakayama R, Honda K, Ichikawa H, Hasegawa T, Shitashige M, Ono M, Shoji A, Sakuma T, Kuwabara H, Shimada Y, Sasako M, Shimoda T, Kawai A, Hirohashi S, Yamada T.

J Clin Oncol. 2008 Sep 1;26(25):4100-8. doi: 10.1200/JCO.2007.14.2331.

PMID:
18757323
9.

Prognostic implications of glucose transporter protein-1 (glut-1) overexpression in bone and soft-tissue sarcomas.

Endo M, Tateishi U, Seki K, Yamaguchi U, Nakatani F, Kawai A, Chuman H, Beppu Y.

Jpn J Clin Oncol. 2007 Dec;37(12):955-60. doi: 10.1093/jjco/hym125.

PMID:
18211986
10.

Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.

Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Kim EE.

Radiology. 2007 Dec;245(3):839-47.

PMID:
18024454
11.

Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population.

Yonemori K, Yamaguchi U, Kaneko M, Uno H, Takeuchi M, Ando M, Fujiwara Y, Hosono A, Makimoto A, Hasegawa T, Yokoyama R, Nakatani F, Kawai A, Beppu Y, Chuman H.

J Cancer Res Clin Oncol. 2008 Mar;134(3):389-95. Epub 2007 Aug 9.

PMID:
17687565
12.

Solitary intramuscular myxoma with monostotic fibrous dysplasia as a rare variant of Mazabraud's syndrome.

Endo M, Kawai A, Kobayashi E, Morimoto Y, Yamaguchi U, Nakatani F, Chuman H, Seki K, Beppu Y.

Skeletal Radiol. 2007 Jun;36(6):523-9. Epub 2006 Dec 1. Review.

PMID:
17139504
13.

Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging.

Tateishi U, Yamaguchi U, Maeda T, Seki K, Terauchi T, Kawai A, Arai Y, Moriyama N, Kakizoe T.

Cancer Sci. 2006 Oct;97(10):1125-8.

14.

Utility of immunohistochemical analysis for cyclo-oxygenase 2 in the differential diagnosis of osteoblastoma and osteosarcoma.

Hosono A, Yamaguchi U, Makimoto A, Endo M, Watanabe A, Shimoda T, Kaya M, Matsumura T, Sonobe H, Kusumi T, Yamaguchi T, Hasegawa T.

J Clin Pathol. 2007 Apr;60(4):410-4. Epub 2006 Jul 5.

15.

Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas.

Endo M, Matsumura T, Yamaguchi T, Yamaguchi U, Morimoto Y, Nakatani F, Kawai A, Chuman H, Beppu Y, Shimoda T, Hasegawa T.

Hum Pathol. 2006 Apr;37(4):471-6. Epub 2006 Feb 3.

PMID:
16564923
16.

Interobserver variability in histologic recognition, interpretation of KIT immunostaining, and determining MIB-1 labeling indices in gastrointestinal stromal tumors and other spindle cell tumors of the gastrointestinal tract.

Yamaguchi U, Hasegawa T, Sakurai S, Sakuma Y, Takazawa Y, Hishima T, Mitsuhashi T, Sekine S, Chuman H, Shimoda T.

Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):46-51.

PMID:
16540730
17.

Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography.

Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Hasegawa T.

Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):683-91. Epub 2006 Feb 28.

PMID:
16506050
18.

Extraskeletal osteosarcoma: extensive tumor thrombus on fused PET-CT images.

Tateishi U, Yamaguchi U, Terauchi T, Maeda T, Moriyama N, Arai Y, Hasegawa T.

Ann Nucl Med. 2005 Dec;19(8):729-32.

PMID:
16445001
19.

Cytogenetic confirmation of a gastrointestinal stromal tumor and ewing sarcoma/primitive neuroectodermal tumor in a single patient.

Kondo S, Yamaguchi U, Sakurai S, Ikezawa Y, Chuman H, Tateishi U, Furuta K, Hasegawa T.

Jpn J Clin Oncol. 2005 Dec;35(12):753-6. Epub 2005 Dec 6.

PMID:
16332719
20.
21.

Blood loss and transfusion associated with musculoskeletal tumor surgery.

Kawai A, Kadota H, Yamaguchi U, Morimoto Y, Ozaki T, Beppu Y.

J Surg Oncol. 2005 Oct 1;92(1):52-8.

PMID:
16180233
22.

Incidence of multiple primary malignancies in a cohort of adult patients with soft tissue sarcoma.

Tateishi U, Hasegawa T, Yamamoto S, Yamaguchi U, Yokoyama R, Kawamoto H, Satake M, Arai Y.

Jpn J Clin Oncol. 2005 Aug;35(8):444-52. Epub 2005 Jul 15.

PMID:
16024533
23.

Bizarre parosteal osteochondromatous proliferation with a t(1;17) translocation.

Endo M, Hasegawa T, Tashiro T, Yamaguchi U, Morimoto Y, Nakatani F, Shimoda T.

Virchows Arch. 2005 Jul;447(1):99-102. Epub 2005 May 31.

PMID:
15926071
24.

Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.

Sato O, Wada T, Kawai A, Yamaguchi U, Makimoto A, Kokai Y, Yamashita T, Chuman H, Beppu Y, Tani Y, Hasegawa T.

Cancer. 2005 May 1;103(9):1881-90.

25.

[Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment].

Yamaguchi U, Hasegawa T.

Gan To Kagaku Ryoho. 2004 Sep;31(9):1340-5. Review. Japanese.

PMID:
15446553
26.

Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis.

Yamaguchi U, Hasegawa T, Masuda T, Sekine S, Kawai A, Chuman H, Shimoda T.

Virchows Arch. 2004 Aug;445(2):142-50. Epub 2004 Jun 30.

PMID:
15232741
27.

Low grade malignant peripheral nerve sheath tumour: varied cytological and histological patterns.

Yamaguchi U, Hasegawa T, Hirose T, Chuman H, Kawai A, Ito Y, Beppu Y.

J Clin Pathol. 2003 Nov;56(11):826-30.

28.

Sclerosing perineurioma: a clinicopathological study of five cases and diagnostic utility of immunohistochemical staining for GLUT1.

Yamaguchi U, Hasegawa T, Hirose T, Fugo K, Mitsuhashi T, Shimizu M, Kawai A, Ito Y, Chuman H, Beppu Y.

Virchows Arch. 2003 Aug;443(2):159-63. Epub 2003 Jun 26.

PMID:
12836021

Supplemental Content

Loading ...
Support Center